Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA RECALLS & COURT ACTIONS: November 17, 1993

Executive Summary

CLASS II -- DMSA KIDNEY REAGENT KIT For the preparation of Technetium TC99m Succimer Injection, Rx intravenous sterile diagnostic radiopharmaceutical. Recall number: D-023-4. Lot numbers: 002, 002A, 002B. Manufacturer Amersham International plc, Gloucester, England. Recalled by: Medi-Physics, Inc., Arlington Heights, Illinois, by letter Oct. 12, 1993. Firm- initiated recall ongoing. Distribution: Nationwide, Canada; 724 kits were distributed; firm estimates 150 kits remain on the market. Reason: Kits bear an expiration date of March 24, 1994 instead of Sept. 24, 1993. CLASS II -- VIDEX (DIDANOSINE) CHEWABLE/DISPERSIBLE BUFFERED TABLETS, 25 MG In 60 tablet bottles, Rx, used in the treatment of AIDS. Recall number D-025-4. Batch code MBE15. Manufacturer: Bristol-Myers Squibb Company, Evansville, Indiana. Recalled by: Bristol-Myers Squibb HIV Products, Princeton, New Jersey, by letter June 3, 1993. Firm- initiated recall complete. Distribution: Nationwide; 207 cases (12 bottles per case) were distributed. Reason: Product does not meet content uniformity specifications. CLASS III -- NOVAFED Brown and orange colored hard gelatin capsules, in bottles of 100, a controlled-release Rx decongestant. Recall number: D-024-4. Lot number 1127BC EXP 12/94. Manufacturer: KV Pharmaceuticals, St Louis, Missouri. Recalled by: Marion Merrell Dow, Inc., Cincinnati, Ohio, by letter Oct. 7, 1993. Firm-initiated recall ongoing. Distribution: Nationwide and Puerto Rico; 19,467 bottles were distributed; firm estimates very little stock remains on the market. Reason: Product failed stability testing for dissolution.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS023633

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel